Showing 20,461 - 20,480 results of 60,557 for search '(( 5 ((we decrease) OR (nn decrease)) ) OR ( 50 ((n decrease) OR (a decrease)) ))', query time: 1.42s Refine Results
  1. 20461
  2. 20462

    Incident Tuberculosis during Antiretroviral Therapy Contributes to Suboptimal Immune Reconstitution in a Large Urban HIV Clinic in Sub-Saharan Africa by Sabine M. Hermans (249344)

    Published 2010
    “…After two years on ART, the patients who had developed TB in the first 12 months had a significantly lower median CD4 count increase (184 cells/mm<sup>3</sup> [IQR; 107, 258, n = 118] vs 209 cells/mm<sup>3</sup> [124, 309, n = 2166], <em>P</em> = 0.01), a larger proportion of suboptimal immune reconstitution according to two definitions (increase in CD4 count <200 cells/mm<sup>3</sup>: 57.4% vs 46.9%, <em>P</em> = 0.03, and absolute CD4 count <200 cells/mm<sup>3</sup>: 30.4 vs 19.9%, <em>P</em> = 0.006), and a higher percentage of immunological failure according to the WHO criteria (13.6% vs 6.5%, <em>P</em> = 0.003). …”
  3. 20463
  4. 20464

    File S1 - Modifications in Rat Plasma Proteome after Remote Ischemic Preconditioning (RIPC) Stimulus: Identification by a SELDI-TOF-MS Approach by Pierre Hibert (470627)

    Published 2014
    “…The continuous line represents the mean, and dots represent each individual rat (n = 10 in each group). Detailed <i>p-</i>value data for comparison between the three groups is indicated in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0085669#pone-0085669-t002" target="_blank">Table 2</a>. …”
  5. 20465

    Image_1_Metyrapone Versus Osilodrostat in the Short-Term Therapy of Endogenous Cushing’s Syndrome: Results From a Single Center Cohort Study.jpg by Mario Detomas (11304897)

    Published 2022
    “…This tendency persisted at T2 (-37.3% vs -50.1%; median drug dose: 1250 mg vs 6 mg) while at T3 a decrease in UFC from T0 was more pronounced in the metyrapone group (-71.5% vs -51.5%; median dose 1250 mg vs 7 mg). …”
  6. 20466

    Table_1_Metyrapone Versus Osilodrostat in the Short-Term Therapy of Endogenous Cushing’s Syndrome: Results From a Single Center Cohort Study.docx by Mario Detomas (11304897)

    Published 2022
    “…This tendency persisted at T2 (-37.3% vs -50.1%; median drug dose: 1250 mg vs 6 mg) while at T3 a decrease in UFC from T0 was more pronounced in the metyrapone group (-71.5% vs -51.5%; median dose 1250 mg vs 7 mg). …”
  7. 20467
  8. 20468
  9. 20469
  10. 20470
  11. 20471
  12. 20472
  13. 20473

    Changes in Microbial Communities, Including both Uncultured and Culturable Bacteria, with Mid-Ocean Ballast-Water Exchange during a Voyage from Japan to Australia by Akiko Tomaru (511024)

    Published 2014
    “…<div><p>We assessed changes in the microbial communities in ballast water during a trans-Pacific voyage from Japan to Australia that included a mid-ocean ballast-water exchange. …”
  14. 20474

    Table 1_Evaluation of microsatellite instability patterns in mismatch repair deficiency: a retrospective analysis of 285 endometrial cancers.docx by Cheng Wang (102692)

    Published 2025
    “…</p>Method<p>We evaluated the microsatellite shift patterns using five NCI-recommended loci in 285 MMR-deficient ECs identified through immunohistochemistry (IHC). …”
  15. 20475

    Dynamics of soluble <i>Fgfr2b</i> expression and impact on AER maintenance after a single Dox-IP injection. by Soula Danopoulos (346564)

    Published 2013
    “…(<b>C</b>) Quantification of <i>soluble Fgfr2b</i> by qRT-PCR indicating a peak of expression at 6 hrs and a steep decrease at 24 hrs. …”
  16. 20476

    Image_3_Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.tif by Jinyan Wang (195882)

    Published 2022
    “…Four of five key Risk scoring genes expression were dysregulated in tumor compared with normal samples. …”
  17. 20477

    Image_1_Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.tif by Jinyan Wang (195882)

    Published 2022
    “…Four of five key Risk scoring genes expression were dysregulated in tumor compared with normal samples. …”
  18. 20478

    Image_2_Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.tif by Jinyan Wang (195882)

    Published 2022
    “…Four of five key Risk scoring genes expression were dysregulated in tumor compared with normal samples. …”
  19. 20479

    Supplementary Material for: Efficacy and safety of finerenone in Asian patients with type 2 diabetes and chronic kidney disease: A FIDELITY analysis by figshare admin karger (2628495)

    Published 2025
    “…Methods For this subanalysis, efficacy outcomes included a CV composite (time to CV death, non-fatal myocardial infarction, non-fatal stroke or hospitalization for heart failure) and kidney composite (kidney failure, sustained ≥57% estimated glomerular filtration rate [eGFR] decrease from baseline over ≥4 weeks or renal death) outcome. …”
  20. 20480

    Supplementary file 1_Exposure-response analyses of venetoclax combined with hypomethylating agents in myelodysplastic syndromes: a retrospective study.docx by Ji-Xin Tian (21710993)

    Published 2025
    “…Compared to VEN 400 mg administered without azole antifungals, concomitant use of azole antifungals with VEN 100 mg resulted in a 100.03% and 18.50% increase in VEN C<sub>0</sub> and C<sub>6</sub>, respectively. …”